Scientists convert stem cells to eye tissue

Research could restore sight in patients

2014-05-06

(Press-News.org) Orlando, Fla. — In two separate studies, scientists have developed methods to convert non-embryonic stem cells into eye cells that could be used to restore sight. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando.

In the first method, researchers converted cells taken from the front of a patient's eye into stem cells, which were then programmed to become nerve cells found in the back of the eye. The second study involved introducing stem cells to a single growth factor, which caused them to develop into tissue resembling the developing eye. Both outcomes will play important roles toward generating sources of transplantable cells to replace damaged tissue in patients with impaired vision.

Abstract Title: Derivation, Characterization and Retinal Neural Induction of Human Tenon's -Derived iPS Cells Presentation Start/End Time: Monday, May 5, 8:30 – 10:15am
Location: Exhibit/Poster Hall SA
Session Number: 218

Abstract Title: The formation of primitive ocular structures and stratified neural retina from human pluripotent stem cells Presentation Start/End Time: Monday, May 5, 8:30 – 10:15am
Location: Exhibit/Poster Hall SA
Session Number: 218

INFORMATION: The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include some 11,500 eye and vision researchers from over 70 countries. ARVO encourages and assists research, training, publication and knowledge-sharing in vision and ophthalmology.

All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.

ELSE PRESS RELEASES FROM THIS DATE:

New gel-based eye fluid aids post-operative healing

2014-05-06

Orlando, Fla. — In an effort to avoid serious side effects suffered after surgery to repair retinal detachment, vision scientists have developed a new product to help stabilize the eye while it heals. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. In a recent study, Healaflow® a gel based on one of the most common compounds found in the liquid that fills the eye, was tested in rabbit eyes. After surgery to repair retinal detachment in the rabbits, Healaflow® did ...

First reversible glue bandage could save injured soldiers' vision

2014-05-06

Orlando, Fla. — Scientists have developed the first reversible glue that could be used on the battlefield to treat eye injuries, potentially saving soldiers' vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. When applied to a wounded eye, the adhesive warms up and becomes sticky, sealing the wound and minimizing further damage while the soldier is transported for treatment. Upon arriving at a hospital, doctors can simply apply cool saline solution to the glue, ...

WHI reports $37.1B economic return on combined hormone therapy clinical trial

2014-05-06

SEATTLE – Economic findings were released today on the Women's Health Initiative (WHI), estrogen plus progestin (E+P) trial. The WHI is one of the largest National Institutes of Health-funded studies ever conducted on women. Housed at the Fred Hutchinson Cancer Research Center in Seattle, it is a 15-year, multimillion-dollar study established in 1991, involving more than 160,000 women nationwide, including some 3,500 in Washington. The overall economic return from the WHI E+P trial indicates that changes in practice stemming from the trial provided a net economic return ...

Novel antioxidant makes old arteries seem young again, CU-Boulder study finds

2014-05-06

An antioxidant that targets specific cell structures—mitochondria—may be able to reverse some of the negative effects of aging on arteries, reducing the risk of heart disease, according to a new study by the University of Colorado Boulder. When the research team gave old mice—the equivalent of 70- to 80-year-old humans—water containing an antioxidant known as MitoQ for four weeks, their arteries functioned as well as the arteries of mice with an equivalent human age of just 25 to 35 years. The researchers believe that MitoQ affects the endothelium, a thin layer of cells ...

Cataract surgery decreases risk of falls in older patients

2014-05-06

Orlando, Fla. — New research finds that cataract surgery dramatically decreases the number of falls individuals suffer due to poor vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. In a study of more than 400 Vietnamese patients who were 50-plus years old with cataracts in both eyes, the number of falls patients suffered before and after cataract surgery was monitored. Researchers found a 78% decrease in the risk of falls the year after patients had cataract ...

Simulated model of eye's 3D structure facilitates stem cells transplant

2014-05-06

Orlando, Fla. — Scientists have developed a model that mimics the complex structure of the cornea to enable the transplant of healthy corneal stem cells. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando Fla. Used to restore sight, corneal stem cells live in a specific physical environment. Transplanting these stem cells requires accurate mimicry of their natural surroundings during transport. In this work, vision scientists have recreated the 3D architecture where corneal ...

Astronomers harness the galaxy's biggest telescope

2014-05-06

An international team of astronomers has made a measurement of a distant neutron star that is one million times more precise than the previous world's best. The researchers were able to use the interstellar medium, the 'empty' space between stars and galaxies that is made up of sparsely spread charged particles, as a giant lens to magnify and look closely at the radio wave emission from a small rotating neutron star. This technique yielded the highest resolution measurement ever achieved, equivalent to being able to see the double-helix structure of our genes from the ...

A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L

2014-05-06

Dr. Ruxu Zhang and colleagues from Third Xiangya Hospital, Central South University in China previously found that the K141N mutation in heat shock protein B8 (HSPB8) was responsible for Charcot-Marie-Tooth disease type 2L in a large Chinese family. Therefore, they generated a transgenic mouse model bearing the K141N mutation in the human HSPB8 gene, and to determine whether this K141NHSPB8 transgenic mouse model would manifest the clinical phenotype of Charcot-Marie-Tooth disease type 2L, and consequently be suitable for use in studies of disease pathogenesis. The K141NHSPB8 ...

Regulatory effects of glial cells on retinal synaptic plasticity

2014-05-06

Different types of retinal damage could induce plastic changes of retinal synapses, which might precede the serious damage of neuron soma. These morphological and functional changes to synapses after retinal injury could explain why many intervention measures protected neurons from death but failed to fully recover the damaged visual function. Therefore, it is necessary to investigate both the protection of synapses as well as protecting neurons from death. Dr. Lihong Zhou and co-workers from Central South University in China suggested that retinal glial cell activation ...

The Pael-R gene does not mediate the changes in rotenone-induced PD model cells

2014-05-06

Currently, the pathogenesis of Parkinson's disease is not entirely clear, but it has been generally considered to be the result of interactions among various genetic and environmental factors. Ting Zou and coworkers from Second Xiangya Hospital, Central South University in China previously found that Parkin mutation causes Parkin-associated endothelin receptor-like receptor (Pael-R) protein deposition, and the associated cytotoxicity leads to dopaminergic neuronal apoptosis. These researchers speculated that the Pael-R gene is possibly involved in the action of rotenone ...

Crystal L. Mackall, MD, FAACR, recognized with the 2025 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology

A novel strategy for detecting trace-level nanoplastics in aquatic environments: Multi-feature machine learning-enhanced SERS quantification leveraging the coffee ring effect

Scientists convert stem cells to eye tissue

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: